257 related articles for article (PubMed ID: 8473726)
1. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
Brooks AG; McCluskey J
J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
[TBL] [Abstract][Full Text] [Related]
2. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents.
Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331
[TBL] [Abstract][Full Text] [Related]
6. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
Kanost D; McCluskey J
Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133
[TBL] [Abstract][Full Text] [Related]
7. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
[TBL] [Abstract][Full Text] [Related]
8. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
10. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ
Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
12. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
[TBL] [Abstract][Full Text] [Related]
13. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
[TBL] [Abstract][Full Text] [Related]
14. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
15. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
Kanost D; Basten A; McCluskey J
Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
17. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
Rosloniec EF; Gay D; Freed JH
J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
[TBL] [Abstract][Full Text] [Related]
18. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116.
Robadey C; Wallny HJ; Demotz S
Eur J Immunol; 1996 Jul; 26(7):1656-9. PubMed ID: 8766576
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes.
Pfeifer JD; Wick MJ; Russell DG; Normark SJ; Harding CV
J Immunol; 1992 Oct; 149(8):2576-84. PubMed ID: 1383320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
